111 related articles for article (PubMed ID: 26048090)
21. Transepithelial transport across Caco-2 cell monolayers of antihypertensive egg-derived peptides. PepT1-mediated flux of Tyr-Pro-Ile.
Miguel M; Dávalos A; Manso MA; de la Peña G; Lasunción MA; López-Fandiño R
Mol Nutr Food Res; 2008 Dec; 52(12):1507-13. PubMed ID: 18727013
[TBL] [Abstract][Full Text] [Related]
22. Peptide inhibitors for angiotensin I-converting enzyme from thermolysin digest of dried bonito.
Yokoyama K; Chiba H; Yoshikawa M
Biosci Biotechnol Biochem; 1992 Oct; 56(10):1541-5. PubMed ID: 1369054
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of proline-rich tripeptides in the pig.
van der Pijl PC; Kies AK; Ten Have GA; Duchateau GS; Deutz NE
Peptides; 2008 Dec; 29(12):2196-202. PubMed ID: 18789987
[TBL] [Abstract][Full Text] [Related]
24. Orally Available Collagen Tripeptide: Enzymatic Stability, Intestinal Permeability, and Absorption of Gly-Pro-Hyp and Pro-Hyp.
Sontakke SB; Jung JH; Piao Z; Chung HJ
J Agric Food Chem; 2016 Sep; 64(38):7127-33. PubMed ID: 27573716
[TBL] [Abstract][Full Text] [Related]
25. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme.
Hirota T; Ohki K; Kawagishi R; Kajimoto Y; Mizuno S; Nakamura Y; Kitakaze M
Hypertens Res; 2007 Jun; 30(6):489-96. PubMed ID: 17664851
[TBL] [Abstract][Full Text] [Related]
26. A head-to-head multi-parametric high content analysis of a series of medium chain fatty acid intestinal permeation enhancers in Caco-2 cells.
Brayden DJ; Gleeson J; Walsh EG
Eur J Pharm Biopharm; 2014 Nov; 88(3):830-39. PubMed ID: 25460147
[TBL] [Abstract][Full Text] [Related]
27. Transepithelial transport characteristics of the antihypertensive peptide, Lys-Val-Leu-Pro-Val-Pro, in human intestinal Caco-2 cell monolayers.
Sun H; Liu D; Li S; Qin Z
Biosci Biotechnol Biochem; 2009 Feb; 73(2):293-8. PubMed ID: 19202266
[TBL] [Abstract][Full Text] [Related]
28. Permeability-enhancing effects of three laurate-disaccharide monoesters across isolated rat intestinal mucosae.
McCartney F; Perinelli DR; Tiboni M; Cavanagh R; Lucarini S; Filippo Palmieri G; Casettari L; Brayden DJ
Int J Pharm; 2021 May; 601():120593. PubMed ID: 33857587
[TBL] [Abstract][Full Text] [Related]
29. Novel antihypertensive hexa- and heptapeptides with ACE-inhibiting properties: from the in vitro ACE assay to the spontaneously hypertensive rat.
Ruiz-Giménez P; Marcos JF; Torregrosa G; Lahoz A; Fernández-Musoles R; Valles S; Alborch E; Manzanares P; Salom JB
Peptides; 2011 Jul; 32(7):1431-8. PubMed ID: 21605609
[TBL] [Abstract][Full Text] [Related]
30. Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion.
Abubakar A; Saito T; Kitazawa H; Kawai Y; Itoh T
J Dairy Sci; 1998 Dec; 81(12):3131-8. PubMed ID: 9891260
[TBL] [Abstract][Full Text] [Related]
31. Labrafac
McCartney F; Caisse P; Dumont C; Brayden DJ
Int J Pharm; 2024 Jun; ():124353. PubMed ID: 38909926
[TBL] [Abstract][Full Text] [Related]
32. Hot topic: Changes in angiotensin-converting enzyme inhibition and concentrations of the tripeptides Val-Pro-Pro and Ile-Pro-Pro during ripening of different Swiss cheese varieties.
Meyer J; Bütikofer U; Walther B; Wechsler D; Sieber R
J Dairy Sci; 2009 Mar; 92(3):826-36. PubMed ID: 19233775
[TBL] [Abstract][Full Text] [Related]
33. Effects of surfactant-based permeation enhancers on mannitol permeability, histology, and electrogenic ion transport responses in excised rat colonic mucosae.
Maher S; Heade J; McCartney F; Waters S; Bleiel SB; Brayden DJ
Int J Pharm; 2018 Mar; 539(1-2):11-22. PubMed ID: 29341916
[TBL] [Abstract][Full Text] [Related]
34. Intestinal transport of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg through a Caco-2 Bbe monolayer.
Vermeirssen V; Deplancke B; Tappenden KA; Van Camp J; Gaskins HR; Verstraete W
J Pept Sci; 2002 Mar; 8(3):95-100. PubMed ID: 11931586
[TBL] [Abstract][Full Text] [Related]
35. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
[TBL] [Abstract][Full Text] [Related]
36. The role of citric acid in oral peptide and protein formulations: relationship between calcium chelation and proteolysis inhibition.
Welling SH; Hubálek F; Jacobsen J; Brayden DJ; Rahbek UL; Buckley ST
Eur J Pharm Biopharm; 2014 Apr; 86(3):544-51. PubMed ID: 24384069
[TBL] [Abstract][Full Text] [Related]
37. The milk-derived peptides Val-Pro-Pro and Ile-Pro-Pro attenuate arterial dysfunction in L-NAME-treated rats.
Nonaka A; Nakamura T; Hirota T; Matsushita A; Asakura M; Ohki K; Kitakaze M
Hypertens Res; 2014 Aug; 37(8):703-7. PubMed ID: 24694646
[TBL] [Abstract][Full Text] [Related]
38. Enzyme-modified cheese exerts inhibitory effects on allergen permeation in rats suffering from indomethacin-induced intestinal inflammation.
Isobe N; Suzuki M; Oda M; Tanabe S
Biosci Biotechnol Biochem; 2008 Jul; 72(7):1740-5. PubMed ID: 18603772
[TBL] [Abstract][Full Text] [Related]
39. Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery.
Kamei N; Morishita M; Ehara J; Takayama K
J Control Release; 2008 Oct; 131(2):94-9. PubMed ID: 18692532
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular activity of milk casein-derived tripeptides and plant sterols in spontaneously hypertensive rats.
Jakala P; Pere E; Lehtinen R; Turpeinen A; Korpela R; Vapaatalo H
J Physiol Pharmacol; 2009 Dec; 60(4):11-20. PubMed ID: 20065492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
